Portfolio company
OVO Biomanufacturing
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops a software platform to manage defective interfering particles, increasing viral vaccine and gene therapy production yields for pharmaceutical manufacturers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Silvia Bio
This company provides a cell profiling platform and media additives to improve biomanufacturing yields and quality for biopharmaceutical manufacturers.
Salve Therapeutics
The company develops a bioengineering platform for designing and testing viral gene therapies to treat genetic disorders for biotechnology and pharmaceutical organisations.
Cellevate
This company develops nanofiber cell culture microcarriers for biopharmaceutical manufacturers to enhance viral vaccine and gene therapy production yields.
Spot Biosystems
This company develops non-viral gene therapy delivery platforms using extracellular vesicles to treat genetic diseases for pharmaceutical partners and healthcare providers.
Bioqore
The company develops AI-driven bioprocessing models and automated wet lab services to optimise drug manufacturing conditions for biotechnology and pharmaceutical companies.
Kytopen
This company develops non-viral gene delivery platforms for biotechnology researchers and pharmaceutical manufacturers to accelerate the production of gene-modified cell therapies.
Ori Biotech
This company develops automated manufacturing platforms for cell and gene therapy developers to scale production of advanced medicines.
Form Bio
This company provides a software platform using artificial intelligence to help biopharmaceutical organisations and researchers design and optimise cell and gene therapies.
